Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sanofi-Aventis S.A. ADR
(NQ:
SNY
)
56.21
+0.98 (+1.77%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,181,369
Open
55.72
Bid (Size)
52.50 (1)
Ask (Size)
56.21 (2)
Prev. Close
55.23
Today's Range
55.56 - 56.32
52wk Range
42.63 - 56.32
Shares Outstanding
1,250,690,553
Dividend Yield
3.39%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ARS Pharmaceuticals 'Neffy Uniquely Positioned With Potential To Change Allergy Treatment Paradigm For First Time In 40 years:' Analyst
August 20, 2024
"FDA recently approved ARS Pharmaceuticals' neffy nasal spray for emergency allergic reactions, offering an alternative to epinephrine autoinjectors like EpiPen. Cantor sees strong market potential and...
Via
Benzinga
Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell?
August 19, 2024
Its 12-month relative strength performance is impressive, but Novavax now faces resistance.
Via
Investor's Business Daily
Performance
YTD
+12.42%
+12.42%
1 Month
+9.79%
+9.79%
3 Month
+15.80%
+15.80%
6 Month
+15.26%
+15.26%
1 Year
+6.14%
+6.14%
More News
Read More
NASDAQ:SNY is probably undervalued for the fundamentals it is displaying.
August 19, 2024
Via
Chartmill
Florida Ruling Upholds GSK's Stance On Once Popular Heart Burn Drug Zantac Not Being Associated With Cancer Risk
August 16, 2024
Via
Benzinga
3 Biotech Stocks to Buy on the Dip: August 2024
August 15, 2024
Via
InvestorPlace
NASDAQ:SNY may be ready to breakout.
August 12, 2024
Via
Chartmill
AnaptysBio Hits Five-Year High After Sanofi Takes A Stake In $100 Million Offering
August 14, 2024
Via
Investor's Business Daily
Novavax Plunges on Earnings Miss: Falling Knife or Buying Opp?
August 12, 2024
Via
MarketBeat
Exposures
COVID-19
FDA Approves ARS Pharma's Once Rejected Neffy Nasal Spray Alternative To EpiPen For Emergency Allergy Treatment
August 09, 2024
Via
Benzinga
Exposures
Product Safety
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Reports on ‘Synergistic Effect’ of Lead Compound Plus GLP-1 in AD Treatment Model
August 08, 2024
Via
Investor Brand Network
COVID-19 Vaccine Maker Novavax Trims Annual Outlook As Q2 Sales Take A Hit
August 08, 2024
Via
Benzinga
Exposures
COVID-19
Sanofi's Approved Blood Cancer Drug Sarclisa Shows Improved Progression-Free Survival In Patients Eligible For Transplant
August 08, 2024
Via
Benzinga
Alzheimer’s Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities
August 06, 2024
Via
FinancialNewsMedia
Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities
August 06, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Where Will Novavax Be in 5 Years?
August 03, 2024
Via
The Motley Fool
Regeneron Pharmaceuticals' Q2 Earnings Exceed Estimates, Driven By Its Top-Selling Eczema And Eye Drugs
August 01, 2024
Via
Benzinga
JPMorgan Just Cut Its Price Target on These 3 Stocks: July 31, 2024
July 31, 2024
Via
InvestorPlace
JPMorgan Just Issued a Warning on Novavax (NVAX) Stock
July 30, 2024
Via
InvestorPlace
Sanofi (SNY) Q2 2024 Earnings Call Transcript
July 25, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong Demand
July 25, 2024
Via
Benzinga
25 Best Artificial Intelligence Stocks to Buy Right Now
July 25, 2024
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Stocks Rebound As US Economy Flexes Muscles, Small Caps Rally, Gold Falls: What's Driving Markets Thursday?
July 25, 2024
Via
Benzinga
Topics
Economy
Exposures
Economy
American Airlines, AstraZeneca And 3 Stocks To Watch Heading Into Thursday
July 25, 2024
Via
Benzinga
AstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China Strife
July 23, 2024
Via
Benzinga
Nasdaq, S&P Futures Slide On More Negative Tech Tidings As Focus Shifts To Q2 GDP Data: Strategist Says Trump Trades May Not Work Even If Ex-President Retakes White House
July 25, 2024
Via
Benzinga
Topics
Government
Stocks
Exposures
Political
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.